Deferred Tax Assets, Valuation Allowance of LISATA THERAPEUTICS, INC. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
LISATA THERAPEUTICS, INC. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • LISATA THERAPEUTICS, INC. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $30,885,000, a 11% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

LISATA THERAPEUTICS, INC. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $30,885,000 +$3,091,000 +11% 31 Dec 2025 10-K 12 Mar 2026 2024 FY
Q4 2024 $27,794,000 +$4,272,000 +18% 31 Dec 2024 10-K 12 Mar 2026 2024 FY
Q4 2023 $23,522,000 +$790,000 +3.5% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q4 2022 $22,732,000 -$17,457,000 -43% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q4 2021 $40,189,000 -$33,980,000 -46% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q4 2020 $74,169,000 -$1,521,000 -2% 31 Dec 2020 10-K 22 Mar 2022 2021 FY
Q4 2019 $75,690,000 +$6,859,000 +10% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q4 2018 $68,831,000 +$2,710,000 +4.1% 31 Dec 2018 10-K 05 Mar 2020 2019 FY
Q4 2017 $66,121,000 31 Dec 2017 10-K 14 Mar 2019 2018 FY
Q4 2014 $20,080,000 -$501,700 -2.4% 31 Dec 2014 10-K 02 Mar 2015 2014 FY
Q4 2013 $20,581,700 +$2,139,800 +12% 31 Dec 2013 10-K 02 Mar 2015 2014 FY
Q4 2012 $18,441,900 +$16,124,000 +696% 31 Dec 2012 10-K 02 Mar 2015 2014 FY
Q4 2011 $2,317,900 -$2,696,100 -54% 31 Dec 2011 10-K 11 Mar 2013 2012 FY
Q4 2010 $5,014,000 31 Dec 2010 8-K 15 Aug 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.